Clinical Trials for 2A Pharma

Explore 1 clinical trials worldwide

Showing 1-1 of 1 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: 2A Pharma

Clinical Trials (1)

NCT06136884
A First-In-Human, Phase 1 Study Evaluating Oral TACC3 PPI Inhibitor, AO-252, in Advanced Solid Tumors With or Without Brain Metastases
PHASE1Recruiting
86 participants
Started: Nov 2, 2023 · Completed: Jan 27, 2028
2 conditions1 sponsor5 locations